Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
about
Genetic contribution to osteoarthritis development: current state of evidenceTranscriptional analysis of micro-dissected articular cartilage in post-traumatic murine osteoarthritis.Aberrant Calreticulin Expression in Articular Cartilage of Dio2 Deficient Mice.Methylation quantitative trait locus analysis of osteoarthritis links epigenetics with genetic riskRadiographic features of hand osteoarthritis in adult Kashin-Beck Disease (KBD): the Yongshou KBD study.Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.Genetic Contribution to the Development of Radiographic Knee Osteoarthritis in a Population Presenting with Nonacute Knee Symptoms a Decade EarlierPhlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis.Implementation of Functional Genomics for Bench-to-Bedside Transition in Osteoarthritis.DNA Methylation in Osteoarthritis.The Epigenomic Landscape in Osteoarthritis.ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.The first international workshop on the epigenetics of osteoarthritis.Adult mice lacking the type 2 iodothyronine deiodinase have increased subchondral bone but normal articular cartilage.The effect of forced exercise on knee joints in Dio2(-/-) mice: type II iodothyronine deiodinase-deficient mice are less prone to develop OA-like cartilage damage upon excessive mechanical stress.New insights into thyroid hormone action.DNA Methylation in Osteoarthritis: Current Status and Therapeutic Implications.Recent Insights into the Contribution of the Changing Hypertrophic Chondrocyte Phenotype in the Development and Progression of Osteoarthritis.
P2860
Q26852663-ABFB900D-C75F-4EFC-90F2-5A1094CEFFF8Q35217087-6CD94900-4718-4FC7-B054-F310CC92E0A8Q36013337-92EE39E9-A67A-45F1-B489-B08F7F81DCCEQ36331594-F67FD75A-1D74-44BA-983F-91F1DB2CEF63Q36625902-397DE21A-A7E5-4567-BDC4-C52A635F0F12Q36773018-B9F0DC07-F17E-4282-9B04-9E008B9D2757Q36861786-EBB43449-FD82-4095-9F07-D049E643B6F8Q36923747-C0905B86-4185-41A0-B94E-0EBEB7C445CFQ38538203-460FC9E5-1C92-4445-AE96-0FF321E69900Q38613955-CB180796-CFEF-4E50-8053-B257EB4C1567Q38689354-B9D74114-B9DB-40EE-BC80-66FAEF830BDEQ38764119-699FED4E-D653-4971-AAF0-8C0D7EEBEDFDQ38888317-F6B9D051-1908-432D-9E23-EE3DCBF9858EQ40246605-62E35409-0386-49DC-B01C-0712F8B91096Q41637712-2B2C5517-F257-4D4E-AC74-7A0D780F2BB7Q48319515-7228D099-D968-4590-9518-48E124B88103Q54974118-39BEFBB8-D79A-4FBC-9B05-23C36C479322Q55379279-7B2D643C-AABD-49CA-92DB-B1DEA6A01364
P2860
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
@en
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
@nl
type
label
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
@en
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
@nl
prefLabel
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
@en
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
@nl
P2093
P2860
P50
P1476
Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
@en
P2093
Arash Darvishan
Barry A Pepers
Bastiaan T Heijmans
Bouke J Duijnisveld
Fons J Verbeek
Gerjo J V M van Osch
Nico Lakenberg
Ruud van der Breggen
Willeke Mc van Roon-Mom
Wouter den Hollander
P2860
P304
P356
10.1136/ANNRHEUMDIS-2013-204739
P407
P50
P577
2014-04-02T00:00:00Z